The effect of measuring insulin- like growth factor I and nitric oxide on prognosis in patients with coronary heart disease

朱志军,黄元伟,朱建华,胡申江

DOI: https://doi.org/10.3321/j.issn:1673-8225.2003.24.008

2003-01-01

Abstract:Aim: To investigate the probable mechanism of insulin-like growth factor 1 (IGF I) in coronary heart disease. Methods: The levels of IGF I and nitric oxide (NO) in 56 patients who were diveded into two group (control group, n = 16; patients group, n = 40) confirmed by coronary angiography were measured. The relationship between the levels of IGF I, NO and the number of narrow artery in coronary heart disease patients was analyzed. Results: The levels of IGF I in patients was lower than that in control group. [(27.23 ± 15.48) μg/L, and (48.02 ± 33.43) μg/L, t = 2.180, P < 0.01]. The levels of IGF I got much lower with the coronary angiography numbers increased. The levels of NO in patients with coronary heart disease were lower than control group [(63.00 ± 10.01) mmol/L and (71.19 ± 13.63) mmol/L, t = 2.937, P < 0.05 respectively. The levels of IGF I and NO got much lower with the many narrow coronary artery numbers than one narrow coronary artery in the patients. There was positive relationship between serum IGF I and NO levels in the patients ( r = 0.425, P < 0.05). Conclusion: IGF I may take part in the pathophysiological process of coronary heart disease and to be realized by regulating NO metabolism.